Insider Transactions in Q3 2021 at Flexion Therapeutics Inc (FLXN)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 02
2021
|
William T. Andrews Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,250
+50.0%
|
-
|
|
Jul 19
2021
|
Michael D. Clayman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,859
-3.97%
|
-
|
|
Jul 19
2021
|
Mark S. Levine General Counsel |
SELL
Open market or private sale
|
Direct |
3,945
-2.87%
|
$23,670
$6.45 P/Share
|
|
Jul 19
2021
|
Adam Muzikant Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,870
-1.77%
|
$11,220
$6.45 P/Share
|
|
Jul 19
2021
|
Kerry Wentworth Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
3,944
-2.73%
|
$23,664
$6.45 P/Share
|
|
Jul 19
2021
|
Christina Willwerth Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
3,945
-2.72%
|
$23,670
$6.45 P/Share
|